In her first Bulletin column as ACS Executive Director, Dr. Patricia L. Turner outlines her strategic priorities for the organization, including expanding the College’s influence as the leading advocate for surgeons and patients.
Describes the results of clinical trials using ctDNA to improve survival for patients at high risk of cancer recurrence.
Several finalized requirements for QPP participation in 2022 are identified, specifically the Merit-based Incentive Payment System and the Advanced Alternative Payment pathway.
Evidence-based green practices and sustainability strategies to reduce waste in the OR are summarized.
Investigating the history of the Manitoba Chapter’s gavel underscores the ACS’ commitment to improving the care of surgical patients.
More in this category
- Looking forward – December 2021
- Letters to the Editor
- Synoptic reporting for cancer surgery: Current requirements and future state
- New campaign encourages patients to Speak Up Against Discrimination in health care
- Importance of surgeon engagement in surgical health policy advocacy
- Looking forward – November 2021
- Tailoring systemic therapy for HER2+ early breast cancer—The CompassHER2 Trials
- New study focuses on distractions, interruptions during surgical counting
- Patient autonomy and end-of-life care: A COVID-19 story
- Dan Elkin and Al Blalock: Present at the Creation
- Looking forward – October 2021
- Where does equity start? An American surgeon’s northern exposure
- Improving patient-centered breast cancer treatment decisions
- Reporting excision of soft tissue tumor codes
- New workplace violence prevention standards take effect January 2022